chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Taste disorder
Clinical narrative: taste issues; doesn't eat or sleep well; doesn't eat or sleep well; Chills; muscle ache; low-grade fever; headache; surge of acid in my mouth; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (surge of acid in my mouth), TASTE DISORDER (taste issues), FEEDING DISORDER (doesn't eat or sleep well), INSOMNIA (doesn't eat or sleep well) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (surge of acid in my mouth). On an unknown date, the patient experienced TASTE DISORDER (taste issues), FEEDING DISORDER (doesn't eat or sleep well), INSOMNIA (doesn't eat or sleep well), CHILLS (Chills), MYALGIA (muscle ache), PYREXIA (low-grade fever) and HEADACHE (headache). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (surge of acid in my mouth), TASTE DISORDER (taste issues), FEEDING DISORDER (doesn't eat or sleep well), INSOMNIA (doesn't eat or sleep well), CHILLS (Chills), MYALGIA (muscle ache), PYREXIA (low-grade fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided. No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-109904 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109904:Husband case
Sex: U
Vaccine: COVID19
Symptoms: Gait disturbance, Myalgia
Clinical narrative: Severe Myalgia causing difficulty in walking; Severe Myalgia causing difficulty in walking; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of GAIT DISTURBANCE (Severe Myalgia causing difficulty in walking) and MYALGIA (Severe Myalgia causing difficulty in walking) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (Severe Myalgia causing difficulty in walking) and MYALGIA (Severe Myalgia causing difficulty in walking). At the time of the report, GAIT DISTURBANCE (Severe Myalgia causing difficulty in walking) and MYALGIA (Severe Myalgia causing difficulty in walking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Joint stiffness, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Joints were stiff), ARTHRITIS (Felt like having major arthritis), MYALGIA (Lot of body aches) and ARTHRALGIA (Joints hurts when stands/Joints pops when stands) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MONTELUKAST SODIUM (SINGULAIR), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), Voltaren Gel, BACLOFEN and LIDOCAINE HYDROCHLORIDE (LIDOCAIN [LIDOCAINE HYDROCHLORIDE]) for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced JOINT STIFFNESS (Joints were stiff), ARTHRITIS (Felt like having major arthritis), MYALGIA (Lot of body aches) and ARTHRALGIA (Joints hurts when stands/Joints pops when stands). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, JOINT STIFFNESS (Joints were stiff), ARTHRITIS (Felt like having major arthritis), MYALGIA (Lot of body aches) and ARTHRALGIA (Joints hurts when stands/Joints pops when stands) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported other concomitant medication as Lidocaine patch   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: TCR was received does not contain any additional information patient ask not to contact her HCP
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Slept through getting the shot; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Slept through getting the shot) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No reported medical history reported.     On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, the patient experienced SLEEP DISORDER (Slept through getting the shot). On 04-May-2021, SLEEP DISORDER (Slept through getting the shot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. Treatment details not reported by the reporter.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Myalgia, Nasal congestion
Clinical narrative: Fever broke,sweating; Head is congested; Feels like I've been run over by a truck/Hurt everywhere; Moderately decent fever; Pain in head/Head pounding; Sweat chills; Extremely nauseous; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Fever broke,sweating), NASAL CONGESTION (Head is congested), MYALGIA (Feels like I've been run over by a truck/Hurt everywhere), PYREXIA (Moderately decent fever) and HEADACHE (Pain in head/Head pounding) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   No Medical History information was reported.  On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced HYPERHIDROSIS (Fever broke,sweating), NASAL CONGESTION (Head is congested), MYALGIA (Feels like I've been run over by a truck/Hurt everywhere), PYREXIA (Moderately decent fever), HEADACHE (Pain in head/Head pounding), CHILLS (Sweat chills) and NAUSEA (Extremely nauseous). At the time of the report, HYPERHIDROSIS (Fever broke,sweating), NASAL CONGESTION (Head is congested), MYALGIA (Feels like I've been run over by a truck/Hurt everywhere), PYREXIA (Moderately decent fever), HEADACHE (Pain in head/Head pounding), CHILLS (Sweat chills) and NAUSEA (Extremely nauseous) outcome was unknown.  Treatment for the event included acetaminophen.  There are no concomitant medication.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Fever broke,sweating; Head is congested; Feels like I've been run over by a truck/Hurt everywhere; Moderately decent fever; Pain in head/Head pounding; Sweat chills; Extremely nauseous; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Fever broke,sweating), NASAL CONGESTION (Head is congested), MYALGIA (Feels like I've been run over by a truck/Hurt everywhere), PYREXIA (Moderately decent fever) and HEADACHE (Pain in head/Head pounding) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   No Medical History information was reported.  On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced HYPERHIDROSIS (Fever broke,sweating), NASAL CONGESTION (Head is congested), MYALGIA (Feels like I've been run over by a truck/Hurt everywhere), PYREXIA (Moderately decent fever), HEADACHE (Pain in head/Head pounding), CHILLS (Sweat chills) and NAUSEA (Extremely nauseous). At the time of the report, HYPERHIDROSIS (Fever broke,sweating), NASAL CONGESTION (Head is congested), MYALGIA (Feels like I've been run over by a truck/Hurt everywhere), PYREXIA (Moderately decent fever), HEADACHE (Pain in head/Head pounding), CHILLS (Sweat chills) and NAUSEA (Extremely nauseous) outcome was unknown.  Treatment for the event included acetaminophen.  There are no concomitant medication.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Pain in knees and wrist feels like it is pulsating), INSOMNIA (Cant sleep because of pain), INFLAMMATION (inflammation), MUSCULOSKELETAL STIFFNESS (leg stiffening at night) and PAIN IN EXTREMITY (arms hands legs in pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced INFLAMMATION (inflammation), MUSCULOSKELETAL STIFFNESS (leg stiffening at night), PAIN IN EXTREMITY (arms hands legs in pain) and DYSSTASIA (difficult to get up). On 05-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and MYALGIA (Extremely muscle pain in legs and knees / muscle pains/excruciating muscle pain). On an unknown date, the patient experienced MUSCLE TWITCHING (Pain in knees and wrist feels like it is pulsating), INSOMNIA (Cant sleep because of pain), DIARRHOEA (diarrhea) and ARTHRALGIA (Pain in knees and wrist/extreme joint pain). The patient was treated with IBUPROFEN at a dose of 200 milligram; IBUPROFEN at a dose of 800 milligram; HYDROCODONE at an unspecified dose and frequency; HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCLE TWITCHING (Pain in knees and wrist feels like it is pulsating), INSOMNIA (Cant sleep because of pain) and DIARRHOEA (diarrhea) outcome was unknown and INFLAMMATION (inflammation), MUSCULOSKELETAL STIFFNESS (leg stiffening at night), PAIN IN EXTREMITY (arms hands legs in pain), DYSSTASIA (difficult to get up), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (Pain in knees and wrist/extreme joint pain) and MYALGIA (Extremely muscle pain in legs and knees / muscle pains/excruciating muscle pain) had not resolved. Based on current available information and the temporal relationship between product use and the start date of the events a causal relationship cannot be excluded. No concomitant medications were provided by reporter. No treatment medications were provided by reporter. This case was linked to MOD-2021-175593. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Significant follow up added: Serious event of Paralysis and other non-serious events added. Outcome of events updated as per narrative. On 07-Jul-2021: Follow-up information received on 07-JUL-2021 contains No Significant Information.; Sender's Comments: Based on current available information and the temporal relationship between product use and the start date of the events a causal relationship cannot be excluded.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), NAUSEA (Severe nausea) and FATIGUE (very tired) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine), Drug allergy (Lipitor), Drug allergy (Pravastatin), Drug allergy (Lorazepam), Drug allergy (Metronidazole), Allergy to antibiotic (Amoxicillin), Allergy to antibiotic (Ciprofloxacin), Drug allergy (Lopressor), Drug allergy (Edarbi), Drug allergy (Bystolic), Drug allergy (Sertaline Hcl), Drug allergy (Succinate ER) and Drug allergy (Spectrum active). Concomitant products included CLINDAMYCIN, ONDANSETRON, OMEPRAZOLE, ACETYLSALICYLIC ACID (ASPIRIN 81), AMLODIPINE, CARBIDOPA, LEVODOPA (LEVODOPA/CARBIDOPA), TESTOSTERONE and PARACETAMOL (TYLENOL) for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced HEADACHE (Headache) and CHILLS (Chills). On 05-May-2021, the patient experienced NAUSEA (Severe nausea) and FATIGUE (very tired). At the time of the report, HEADACHE (Headache), CHILLS (Chills), NAUSEA (Severe nausea) and FATIGUE (very tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment  Medications information included anti-nausea medication.   This case was linked to MOD-2021-237652 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: follow-up received on 5June2021 contain Patients demographic. 2.concomitant medications like Tylenol added and certain doses are updated.
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: His primary doctor has been experiencing ringing in the ear after receiving vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (His primary doctor has been experiencing ringing in the ear after receiving vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (His primary doctor has been experiencing ringing in the ear after receiving vaccine). At the time of the report, TINNITUS (His primary doctor has been experiencing ringing in the ear after receiving vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient second dose will be out of the 36 day window if he receives it; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient second dose will be out of the 36 day window if he receives it) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient second dose will be out of the 36 day window if he receives it). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient second dose will be out of the 36 day window if he receives it) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment details were provided    Reporter did not allow further contact
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pain in extremity
Clinical narrative: Headache; Fatigue; General body aches; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache), FATIGUE (Fatigue) and MYALGIA (General body aches) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm), FATIGUE (Fatigue) and MYALGIA (General body aches). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache), FATIGUE (Fatigue) and MYALGIA (General body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       After receiving vaccine, the patient experienced pain in arm, fatigue, general body aches and headaches.  Concomitant medications were not reported.  No treatment details were provided
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: "Developed a bump on my lip; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING ("Developed a bump on my lip) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN for Diabetes.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced LIP SWELLING ("Developed a bump on my lip). At the time of the report, LIP SWELLING ("Developed a bump on my lip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include High blood pressure medication and Cholesterol medication. Patient treatment information was not provided.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm for a couple of days) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm for a couple of days). At the time of the report, PAIN IN EXTREMITY (Sore arm for a couple of days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  No treatment details were provided    This case was linked to MOD-2021-110199 (Patient Link).
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: the nurse after injecting the first shot said it is empty and drew one more dose and gave another; This spontaneous case was reported by a consumer and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the nurse after injecting the first shot said it is empty and drew one more dose and gave another) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE for Blood pressure.    On 06-May-2021 at 9:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the nurse after injecting the first shot said it is empty and drew one more dose and gave another). On 06-May-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the nurse after injecting the first shot said it is empty and drew one more dose and gave another) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The Patient did not experienced any side effects after getting the doses.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Additional reporter details, Event verbatim updated,additional information added.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Inappropriate schedule of product administration, Lymphadenopathy, Neck pain
Clinical narrative: Mild neck pain; Swollen lymph nodes; A little tired; Received second vaccine outside dosing window; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second vaccine outside dosing window), NECK PAIN (Mild neck pain), LYMPHADENOPATHY (Swollen lymph nodes) and FATIGUE (A little tired) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second vaccine outside dosing window). On 01-May-2021, the patient experienced NECK PAIN (Mild neck pain), LYMPHADENOPATHY (Swollen lymph nodes) and FATIGUE (A little tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second vaccine outside dosing window), NECK PAIN (Mild neck pain), LYMPHADENOPATHY (Swollen lymph nodes) and FATIGUE (A little tired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had some reactions after her first dose and turned away due at her second dose due to that reaction. Then after consulting her health care professional she had her second dose and the next day she experienced mild neck pain, lymph node swelling and a little bit tired.  Concomitant medications were not reported.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash, Vaccination site warmth
Clinical narrative: Rash back; Hot to the touch injection site; Sore arm; Red injection site; Rash in injection site small dinner plate size; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to the touch injection site), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Red injection site), VACCINATION SITE RASH (Rash in injection site small dinner plate size) and VACCINATION SITE RASH (Rash back) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Hot to the touch injection site), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE RASH (Rash in injection site small dinner plate size). On 04-May-2021, the patient experienced VACCINATION SITE RASH (Rash back). On 22-Apr-2021, VACCINATION SITE WARMTH (Hot to the touch injection site), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE RASH (Rash in injection site small dinner plate size) had resolved. At the time of the report, VACCINATION SITE RASH (Rash back) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The reporter was calling on behalf of their daughter who received their first Moderna vaccine and experienced sore arm, red and hot to touch injection site and rash in injection site small dinner plate size for 3 days.   Reportedly, on 04-May-2021 the rash appeared back.  No Concomitant product use was reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-109778 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109778:Reporter's case
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot to the touch Injection Site (After Second Vaccine); Swelling Doubled up in Size (Involving the entire Upper Arm); Itchy Injection Site (After Second Vaccine); Hard to the Touch Injection Site (After Second Vaccine); A Little Swollen Injection Site (After Second Vaccine); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to the touch Injection Site (After Second Vaccine)), PERIPHERAL SWELLING (Swelling Doubled up in Size (Involving the entire Upper Arm)), VACCINATION SITE PRURITUS (Itchy Injection Site (After Second Vaccine)), VACCINATION SITE SWELLING (A Little Swollen Injection Site (After Second Vaccine)) and VACCINATION SITE PAIN (Hard to the Touch Injection Site (After Second Vaccine)) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE SWELLING (A Little Swollen Injection Site (After Second Vaccine)). On 06-May-2021, the patient experienced VACCINATION SITE WARMTH (Hot to the touch Injection Site (After Second Vaccine)), PERIPHERAL SWELLING (Swelling Doubled up in Size (Involving the entire Upper Arm)), VACCINATION SITE PRURITUS (Itchy Injection Site (After Second Vaccine)) and VACCINATION SITE PAIN (Hard to the Touch Injection Site (After Second Vaccine)). At the time of the report, VACCINATION SITE WARMTH (Hot to the touch Injection Site (After Second Vaccine)), PERIPHERAL SWELLING (Swelling Doubled up in Size (Involving the entire Upper Arm)), VACCINATION SITE PRURITUS (Itchy Injection Site (After Second Vaccine)), VACCINATION SITE SWELLING (A Little Swollen Injection Site (After Second Vaccine)) and VACCINATION SITE PAIN (Hard to the Touch Injection Site (After Second Vaccine)) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  No relevant concomitant medications were reported.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Migraine
Clinical narrative: Headache/ pain close to migraine; I also have chills (getting hot and cold at random times); Am really tired as well; This spontaneous case was reported by a patient and describes the occurrence of MIGRAINE (Headache/ pain close to migraine), CHILLS (I also have chills (getting hot and cold at random times)) and FATIGUE (Am really tired as well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Headache/ pain close to migraine), CHILLS (I also have chills (getting hot and cold at random times)) and FATIGUE (Am really tired as well). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, MIGRAINE (Headache/ pain close to migraine), CHILLS (I also have chills (getting hot and cold at random times)) and FATIGUE (Am really tired as well) outcome was unknown. Not Provided          Patient reported that, she had headaches every day since receiving the vaccine and the pain was close to migraine. Patient also had chills (getting hot and cold at random times) and was tired well.  Concomitant medications were not reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash spread to chest, back and legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash spread to chest, back and legs) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 immunisation.     No Medical History information was reported.   On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash spread to chest, back and legs). At the time of the report, RASH (Rash spread to chest, back and legs) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.   This case was linked to MOD-2021-110113 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Pruritus
Clinical narrative: Mild reaction; itching; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Mild reaction) and PRURITUS (itching) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Mild reaction) and PRURITUS (itching). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (Mild reaction) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   This case was linked to MOD-2021-110201 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Myalgia
Clinical narrative: a little sore; felt a little bad; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (a little sore) and FEELING ABNORMAL (felt a little bad) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 008B212A) for COVID-19 vaccination.     Concomitant products included SALBUTAMOL (ALBUTEROL HFA), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), LEVOCETIRIZINE, CYCLOBENZAPRINE, ATORVASTATIN, MONTELUKAST, MELOXICAM and DOCUSATE SODIUM (STOOL SOFTENER) for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced MYALGIA (a little sore) and FEELING ABNORMAL (felt a little bad). At the time of the report, MYALGIA (a little sore) and FEELING ABNORMAL (felt a little bad) outcome was unknown. Not Provided          This case was linked to MOD-2021-110260 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Been a while since the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Been a while since the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Been a while since the first dose). On 15-Feb-2021, PRODUCT DOSE OMISSION ISSUE (Been a while since the first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Rectal discharge
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RECTAL DISCHARGE (episodes of very very light brown fluid rectal discharges), DIARRHOEA (diarrhea) and FATIGUE (episodes of fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced RECTAL DISCHARGE (episodes of very very light brown fluid rectal discharges), DIARRHOEA (diarrhea) and FATIGUE (episodes of fatigue). At the time of the report, RECTAL DISCHARGE (episodes of very very light brown fluid rectal discharges), DIARRHOEA (diarrhea) and FATIGUE (episodes of fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Patient received first shot of shingle on December 2020. No Relevant concomitant medications was reported. Treatment information included patient took low dense food and electrolyte for the episodes of rectal discharges.   This case was linked to US-MODERNATX, INC.-MOD-2021-039318 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-039318:1st dose
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Musculoskeletal chest pain, Nasopharyngitis
Clinical narrative: Rib pain; Cold; Headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Rib pain), NASOPHARYNGITIS (Cold), HEADACHE (Headache) and CHILLS (chills ) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (Rib pain), NASOPHARYNGITIS (Cold), HEADACHE (Headache) and CHILLS (chills ). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Rib pain), NASOPHARYNGITIS (Cold), HEADACHE (Headache) and CHILLS (chills ) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medicines were reported. No treatment information were reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Temperature of 99/highest temperature is 101; Running fever; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE (Temperature of 99/highest temperature is 101) and PYREXIA (Running fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B212A and 025B21A) for COVID-19 vaccination.     Concomitant products included ALBUTEROL [SALBUTAMOL], BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), LEVOCETIRIZINE, CYCLOBENZAPRINE, ATORVASTATIN, MONTELUKAST, MELOXICAM and DOCUSATE SODIUM (STOOL SOFTENER) for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced BODY TEMPERATURE (Temperature of 99/highest temperature is 101) and PYREXIA (Running fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, BODY TEMPERATURE (Temperature of 99/highest temperature is 101) and PYREXIA (Running fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (Inconclusive) Inconclusive and 99 (Inconclusive) Inconclusive.         After second dose, patient started running fever and the temperature was 99. Then the temperature increased to 101.   This case was linked to MOD-2021-110226 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Back pain, Confusional state, Depression, Eye pruritus
Clinical narrative: bleeding started,heavy period,; hot flashes; hot flashes increased; back hurts; itchy in eyes; confused; feels depressed; anxiety increased; small rash; body aches; had headaches; was tired; swollen hands; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts) and EYE PRURITUS (itchy in eyes) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CIMICIFUGA RACEMOSA ROOT, GLYCINE MAX EXTRACT (BLACK COHOSH & SOY ISOFLAVONES), ESTRADIOL, CLOBETASOL PROPIONATE, LORAZEPAM and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PERIPHERAL SWELLING (swollen hands). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts), EYE PRURITUS (itchy in eyes), CONFUSIONAL STATE (confused), DEPRESSION (feels depressed), ANXIETY (anxiety increased), RASH (small rash), PAIN (body aches), HEADACHE (had headaches) and FATIGUE (was tired). At the time of the report, HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts), EYE PRURITUS (itchy in eyes), CONFUSIONAL STATE (confused), PERIPHERAL SWELLING (swollen hands), DEPRESSION (feels depressed), ANXIETY (anxiety increased), RASH (small rash), PAIN (body aches), HEADACHE (had headaches) and FATIGUE (was tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no treatment drugs were provided.   This case was linked to MOD-2021-076311 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heavy menstrual bleeding, Hot flush, Pain
Clinical narrative: bleeding started,heavy period,; hot flashes; hot flashes increased; back hurts; itchy in eyes; confused; feels depressed; anxiety increased; small rash; body aches; had headaches; was tired; swollen hands; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts) and EYE PRURITUS (itchy in eyes) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CIMICIFUGA RACEMOSA ROOT, GLYCINE MAX EXTRACT (BLACK COHOSH & SOY ISOFLAVONES), ESTRADIOL, CLOBETASOL PROPIONATE, LORAZEPAM and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PERIPHERAL SWELLING (swollen hands). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts), EYE PRURITUS (itchy in eyes), CONFUSIONAL STATE (confused), DEPRESSION (feels depressed), ANXIETY (anxiety increased), RASH (small rash), PAIN (body aches), HEADACHE (had headaches) and FATIGUE (was tired). At the time of the report, HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts), EYE PRURITUS (itchy in eyes), CONFUSIONAL STATE (confused), PERIPHERAL SWELLING (swollen hands), DEPRESSION (feels depressed), ANXIETY (anxiety increased), RASH (small rash), PAIN (body aches), HEADACHE (had headaches) and FATIGUE (was tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no treatment drugs were provided.   This case was linked to MOD-2021-076311 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: bleeding started,heavy period,; hot flashes; hot flashes increased; back hurts; itchy in eyes; confused; feels depressed; anxiety increased; small rash; body aches; had headaches; was tired; swollen hands; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts) and EYE PRURITUS (itchy in eyes) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CIMICIFUGA RACEMOSA ROOT, GLYCINE MAX EXTRACT (BLACK COHOSH & SOY ISOFLAVONES), ESTRADIOL, CLOBETASOL PROPIONATE, LORAZEPAM and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PERIPHERAL SWELLING (swollen hands). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts), EYE PRURITUS (itchy in eyes), CONFUSIONAL STATE (confused), DEPRESSION (feels depressed), ANXIETY (anxiety increased), RASH (small rash), PAIN (body aches), HEADACHE (had headaches) and FATIGUE (was tired). At the time of the report, HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts), EYE PRURITUS (itchy in eyes), CONFUSIONAL STATE (confused), PERIPHERAL SWELLING (swollen hands), DEPRESSION (feels depressed), ANXIETY (anxiety increased), RASH (small rash), PAIN (body aches), HEADACHE (had headaches) and FATIGUE (was tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no treatment drugs were provided.   This case was linked to MOD-2021-076311 (Patient Link).